Hemostasis Diagnostics Market Targets USD 4 Billion with 7% CAGR Growth
Hemostasis Diagnostics Market , valued at USD 2 billion in 2020, is projected to double to USD 4 billion by 2031, achieving a robust CAGR of 7%. Driven by rising cases of coagulation disorders, technological advancements in diagnostic systems, and increasing healthcare infrastructure, this market is critical for improving patient outcomes in bleeding disorders. This press release explores key growth drivers, projections, and opportunities for stakeholders in this vital healthcare sector. Why Is the Market Growing? The Hemostasis Diagnostics Market is expanding due to the rising prevalence of coagulation disorders, such as hemophilia affecting 20,000 Americans in 2019, and increasing surgical procedures requiring bleeding risk assessment. Technological advancements, like automated blood coagulation analyzers and point-of-care testing systems, improve diagnostic accuracy by 25%. Growing awareness of hemostatic defects, coupled with aging populations and rising chronic diseases, drive...